Results 111 to 120 of about 42,544 (264)

Association between HBV genotype, HBeAg status and viral load. [PDF]

, 2015
GT, genotype; HBV DNA, hepatitis B viral DNA; HBeAg, hepatitis B e antigenAssociation between HBV genotype, HBeAg status and viral load.
Leland Yee (706287), Patrick Marcellin (706289), Phillip Dinh (706286), Stuart C. Gordon (706284), Scott Fung (706285), Eduardo Bruno Martins (706288), Maria Buti (161144), Tram T. Tran (706283)   +7 more
core   +1 more source

Changes in the Prevalence of HBsAg and HBeAg: a Study of 8696 Parturients in a Well Vaccinated Area

Scientific Reports, 2017
To elucidate the impact of a hepatitis B (HB) vaccination program on the prevalence of HB surface antigen (HBsAg) and HB envelope antigen (HBeAg) as well as the success rate of HBeAg clearance among parturients, we collected data on parturients who gave ...
Chen-Hsuan Wu, Te-Yao Hsu, Fu-Tsai Kung, Chan-Chao ChangChien, Ching-Chang Tsai, Sheng-Nan Lu   +5 more
doaj   +1 more source

Efficacy and safety of long term entecavir in chronic hepatitis B treatment naïve patients in clinical practice

Annals of Hepatology, 2014
Background and aims. Entecavir (ETV) is effective and safe in patients with chronic hepatitis B in the short term, but its long term efficacy and safety has not been established.Material and methods.
Ezequiel Ridruejo, Sebastián Marciano, Omar Galdame, María V. Reggiardo, Alberto E. Muñoz, Raúl Adrover, Daniel Cocozzella, Nora Fernandez, Claudio Estepo, Manuel Mendizabal, Gustavo A. Romero, Diana Levi, Teresa Schroder, Silvia Paz, Hugo Fainboim, Oscar G. Mandó, Adrián C. Gadano, Marcelo O. Silva   +17 more
doaj   +1 more source

Barriers to Hepatitis B Treatment: A Multicentre Cross‐Sectional Registry and Survey Study by the Canadian Hepatitis B Network

Liver International, Volume 46, Issue 9, September 2026.
ABSTRACT Background & Aims Chronic hepatitis B (CHB) remains a leading cause of cirrhosis and hepatocellular carcinoma (HCC) worldwide, yet treatment uptake is suboptimal even in high‐resource settings. This pan‐Canadian study aimed to quantify treatment gaps within the Canadian Hepatitis B Network (CanHepB) Registry, compare characteristics of ...
Hin Hin Ko, Jordyn Vienneau, Curtis L. Cooper, Pam Crotty, Stephen E. Congly, Mayur Brahmania, Alnoor Ramji, Erin Kelly, Angela M. Crawley, Karen Doucette, Vanessa Meier‐Stephenson, Mang Ma, Scott K. Fung, David K. Wong, Jordan Feld, Nabiha Faisal, Kelly Kaita, Carla Osiowy, Magdy Elkhashab, Edward Tam, Alexander Wong, Robert Bailey, Philip Wong, Giada Sebastiani, Tianyan Chen, Brian Conway, David Truong, Keith Tsoi, Carmine Nudo, Julie Zhu, Sébastien Poulin, Abdel‐Aziz Shaheen, Carla S. Coffin   +32 more
wiley   +1 more source

Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA

Medicine, 2017
This study aimed to investigate the correlation between quantitative hepatitis B e antigen (HBeAg) and hepatitis B virus (HBV) DNA levels, and to determine whether semiquantitative measurement of HBeAg can indicate the extent of HBV replication in HBeAg ...
Ping Chen, Qinfen Xie, Xuan Lu, Chengbo Yu, Kaijin Xu, B. Ruan, H. Cao, Hainv Gao, Lanjuan Li   +8 more
semanticscholar   +1 more source

Perbedaan Kadar Tumor Necrosis Factor Alpha Antara HBeAg Positif Dengan HBeAg Negatif Pada Hepatitis B [PDF]

, 2017
Hepatitis B adalah infeksi hati yang disebabkan oleh virus Hepatitis B, merupakan penyebab utama hepatitis akut dan bisa berlanjut menjadi hepatitis kronis, sirosis serta kanker hati.
Chairina, Chairina
core  

HBeAg status in the four age cohorts. [PDF]

, 2015
HBeAg status in the four age cohorts.
Leland Yee (706287), Patrick Marcellin (706289), Phillip Dinh (706286), Stuart C. Gordon (706284), Scott Fung (706285), Eduardo Bruno Martins (706288), Maria Buti (161144), Tram T. Tran (706283)   +7 more
core   +1 more source

Deteksi HBsAg dan HBeAg dalam Saliva Pengidap Virus Hepatitis B [PDF]

, 2015
Transmission of hepatitis B virus (HBV) via blood or its product has been well established. However, body fluids like urine and saliva may also contain HBV. A complete HBV consists of HBsAg, HBeAg, HBcAg dan partikel DNA.
Lesmana, Riemawati A.; Department of Prosthodontics, Faculty of Dentistry, Universitas Indonesia, Jakarta 10430
core   +3 more sources

Combination of Peginterferon α-2b (12 kDa) and Lamivudine in difficult-to-treat chronic hepatitis B-an Indian experience

Annals of Hepatology, 2005
Introduction: Treatment strategies for chronic hepatitis B (CHB) using either interferon or Lamivudine can achieve sustained response in 30-40 % in HBeAg positive CHB.
Deepak N. Amarapurkar, Nikhil D. Patel
doaj   +1 more source

From Treatment Discontinuation to Aggressive Recurrence: A Cautionary Case Report of Rapid Progression to Invasive Carcinoma Following Torimifene‐Induced Hepatotoxicity and Drug Withdrawal in a Patient With Completely Resected Intraductal Papillary Carcinoma

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Even ‘low‐risk’ intraductal papillary carcinoma can progress rapidly to invasive disease following unplanned discontinuation of adjuvant endocrine therapy, as illustrated by this case where hepatotoxicity led to treatment cessation and early recurrence.
Lanya Yu, Zhe He, Guibin Qiao
wiley   +1 more source